Humoral antibodies in organ transplantation: Angels or demons?: Letter to the editor

American Journal of Transplantation

Volumn 10, Issue 5, 2010, Pages 1332-

  Ponticelli, Claudio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HUMORAL ANTIBODY;

CHRONIC GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; HUMORAL IMMUNITY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTECTION; TREATMENT OUTCOME;

ANTIBODIES; FEMALE; HUMANS; MALE;

EID: 77951222296     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02990.x     Document Type: Letter

References (4)

1. Hidalgo LG, Campbell PM, Sis B et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009 9 : 2532 2541.
2. Chang AT, Platt JL. The role of antibodies in transplantation. Transplant Rev 2009 23 : 191 198
3. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998 4 : 1392 1396. (Pubitemid 28553461)
4. Jindra PT, Zhang X, Mulder A et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006 82 (Suppl 1 S33 S35. (Pubitemid 44035984)